Literature DB >> 16809032

Prognostic factors for progression of childhood optic pathway glioma: a systematic review.

Enrico Opocher1, Leontien C M Kremer, Liviana Da Dalt, Marianne D van de Wetering, Elisabetta Viscardi, Huib N Caron, Giorgio Perilongo.   

Abstract

A systematic literature review was carried out to evaluate best existing evidence on prognostic factors for progression of childhood optic pathway glioma. Databases were searched for relevant articles and articles selected independently by two authors. Information about study design, population, treatment, outcome and prognostic analysis were abstracted and the quality of each article was assessed. A total of 23 articles met the inclusion criteria. Many studies had important methodological limitations, regarding external and internal validity. Eleven studies evaluated possible prognostic factors in a multivariate analysis. Three high-quality studies indicated age<1 year as an independent prognostic factor for a worse progression-free survival. Three studies with multivariate analysis, including one high-quality study, found that children with neurofibromatosis type 1 (NF-1) have a better progression-free survival than those without NF-1. Two studies with multivariate analysis found tumour site to be a prognostic factor, both with some methodological limitations. In conclusion, this systematic review demonstrates that only a few of the prognostic factors proposed have been proven to be clinically relevant. Age<1 year is a clear and independent prognostic factor for progression-free survival. Other prognostic factors, such as NF-1, tumour site and others, are suggested, but are still without solid evidence and need further high-quality studies to be clearly proven.

Entities:  

Mesh:

Year:  2006        PMID: 16809032     DOI: 10.1016/j.ejca.2006.02.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  43 in total

1.  Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

Authors:  Anthony P Y Liu; Camden Hastings; Shengjie Wu; Johnnie K Bass; Andrew M Heitzer; Jason Ashford; Robert Vestal; Mary E Hoehn; Yahya Ghazwani; Sahaja Acharya; Heather M Conklin; Frederick Boop; Thomas E Merchant; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

Review 2.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

3.  Suprasellar pilocytic astrocytoma: one national centre's experience.

Authors:  Tafadzwa Mandiwanza; Chandrasekaran Kaliaperumal; Ayman Khalil; Muhammad Sattar; Darach Crimmins; John Caird
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

4.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

Review 5.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

6.  Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US.

Authors:  Marios K Georgakis; Maria A Karalexi; Eleni I Kalogirou; Anton Ryzhov; Anna Zborovskaya; Nadya Dimitrova; Sultan Eser; Luis Antunes; Mario Sekerija; Tina Zagar; Joana Bastos; Domenic Agius; Margareta Florea; Daniela Coza; Evdoxia Bouka; Charis Bourgioti; Helen Dana; Emmanuel Hatzipantelis; Maria Moschovi; Savvas Papadopoulos; Georgios Sfakianos; Evgenia Papakonstantinou; Sophia Polychronopoulou; Spyros Sgouros; Kalliopi Stefanaki; Eftichia Stiakaki; Katerina Strantzia; Basilios Zountsas; Apostolos Pourtsidis; Eustratios Patsouris; Eleni Th Petridou
Journal:  J Neurooncol       Date:  2016-10-14       Impact factor: 4.130

Review 7.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

8.  Challenges in the management of childhood low-grade glioma in a developing country.

Authors:  Khalid Abdalla; Shaker Abdullah; Abeer Almehdar; Naglla Elimam; Mohammed Burhan Abrar; Wasil Jastaniah
Journal:  Childs Nerv Syst       Date:  2018-02-02       Impact factor: 1.475

9.  Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.

Authors:  Kavita K Mishra; Sarah Squire; Kathleen Lamborn; Anuradha Banerjee; Nalin Gupta; William M Wara; Michael D Prados; Mitchel S Berger; Daphne A Haas-Kogan
Journal:  J Neurooncol       Date:  2010-03-11       Impact factor: 4.130

Review 10.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.